Dyne Therapeutics
196 hedge funds and large institutions have $1.23B invested in Dyne Therapeutics in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 95 increasing their positions, 52 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 204 → 196 (-8)
23% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 30
53% less call options, than puts
Call options by funds: $390K | Put options by funds: $823K
Holders
196
Holding in Top 10
6
Calls
$390K
Puts
$823K
Top Buyers
| 1 | +$30.4M | |
| 2 | +$20.2M | |
| 3 | +$13.9M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$13.8M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$13.3M |
Top Sellers
| 1 | -$20.9M | |
| 2 | -$19.7M | |
| 3 | -$13.4M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$10.2M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$8.72M |
